
Number of publications published per year by Popov, Yury. (Source : PubMed)

Distribution of publications types for Popov, Yury. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis.
Am. J. Physiol. Gastrointest. Liver Physiol.
2010;298;3
Role of the receptor for advanced glycation end products in hepatic fibrosis.
World J. Gastroenterol.
2009;15;46

Gliadin-primed CD4+CD45RBlowCD25- T cells drive gluten-dependent small intestinal damage after adoptive transfer into lymphopenic mice.
Gut
2009;58;12

Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis.
Hepatology
2009;50;5
CD8+ T cells drive adipose tissue inflammation - A novel clue for NASH pathogenesis?
J. Hepatol.
2009


Rationale and targets for antifibrotic therapies.
Gastroenterol. Clin. Biol.
2009;33;10-11


Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies.
Hepatology
2009;50;4

Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans.
J. Clin. Invest.
2008;118;10

The hedgehog pathway regulates remodelling responses to biliary obstruction in rats.
Gut
2008;57;9

Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
Gastroenterology
2008;135;2
[ See timeline ] [ See all publications ]
means that Popov, Yury has 11 papers cited a least 11 times - methodology
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.